Biocon Surges as ₹3,680 Crore Block Deal Clears Overhang

Biocon shares jumped nearly 6% after a ₹3,680 crore block deal saw Mylan sell its entire 5.64% stake, removing a key supply overhang. The stock emerged as the top BSE MidCap gainer, with investors cheering the exit of a major shareholder and improved sentiment.